22 June, 2026 | Monday | Analysis

For most of the last decade, the anxiety in Asia-Pacific biomanufacturing pointed upstream. The conversation was about bioreactor volume — how many thousands of litres a campus could install, how fast a C...

16 June, 2026 | Tuesday | News

Planned gene expression assay launches and high-multiplex capabilities are expected to expand QIAcuity into one of the largest molecular biology application areas Expanded Cell and Gene Therapy offerin...

23 June, 2026 | Tuesday | News

The total funding comprises US$1 million in angel investment and a US$4 million seed round. The seed financing round was led by Wavemaker Ventures, with participation by SEEDS, further sup...

24 June, 2026 | Wednesday | Analysis

For two decades the contract development and manufacturing organisation occupied a comfortable, clearly understood place in the biopharma value chain. The innovator owned the molecule and the science; the CDMO ...

10 June, 2026 | Wednesday | News

As healthcare systems across Asia Pacific confront mounting workforce shortages, ageing populations, and rising chronic disease burdens, artificial intelligence is emerging as a critical enabler of more efficie...

22 June, 2026 | Monday | News

Ethics approval received from the Alfred Hospital Human Research Ethics Committee (Bayside Health) for Phase 2b KappaMab™ clinical trial “HLX-KM-04” Study will evaluate safety and efficacy ...

24 June, 2026 | Wednesday | News

CARsgen Therapeutics Holdings Limited (Stock Code: 2171.HK), a company focused on developing innovative CAR T-cell therapies, announced that as informed by the National Medical Products Administration ("NMPA") ...